BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25993215)

  • 1. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
    Crew KD
    Am Soc Clin Oncol Educ Book; 2015; ():e50-8. PubMed ID: 25993215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention.
    Reimers L; Crew KD
    Curr Breast Cancer Rep; 2012 Sep; 4(3):207-215. PubMed ID: 23956815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine prevention of breast cancer.
    Jahan N; Jones C; Rahman RL
    Mol Cell Endocrinol; 2021 Jun; 530():111284. PubMed ID: 33882282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider.
    Farkas A; Vanderberg R; Merriam S; DiNardo D
    J Womens Health (Larchmt); 2020 Jan; 29(1):46-56. PubMed ID: 31560601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.
    Vogel VG
    Curr Drug Targets; 2011 Dec; 12(13):1874-87. PubMed ID: 21158712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in breast cancer chemoprevention.
    Chlebowski RT
    Pol Arch Med Wewn; 2014; 124(4):191-9. PubMed ID: 24618912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer prevention.
    Euhus DM; Diaz J
    Breast J; 2015; 21(1):76-81. PubMed ID: 25413630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians.
    Ball S; Arevalo M; Juarez E; Payne JD; Jones C
    Prev Med; 2019 Dec; 129():105834. PubMed ID: 31494144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exemestane for primary prevention of breast cancer in postmenopausal women.
    Zhang Y; Simondsen K; Kolesar JM
    Am J Health Syst Pharm; 2012 Aug; 69(16):1384-8. PubMed ID: 22855103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    Levine M; Moutquin JM; Walton R; Feightner J;
    CMAJ; 2001 Jun; 164(12):1681-90. PubMed ID: 11450210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.
    Mocellin S; Pilati P; Briarava M; Nitti D
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer.
    Aktas B; Sorkin M; Pusztai L; Hofstatter EW
    Eur J Cancer Prev; 2016 Jan; 25(1):3-8. PubMed ID: 25642790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Fu R; Zakher B; Pappas M; McDonagh M
    JAMA; 2019 Sep; 322(9):868-886. PubMed ID: 31479143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hormones in cancer prevention.
    Vogel VG
    Am Soc Clin Oncol Educ Book; 2014; ():34-40. PubMed ID: 24857058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention for Breast Cancer.
    Pruthi S; Heisey RE; Bevers TB
    Ann Surg Oncol; 2015 Oct; 22(10):3230-5. PubMed ID: 26202562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
    Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
    Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hormone-related cancers: breast cancer.
    Dunn BK; Wickerham DL; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision making in the context of breast cancer chemoprevention: patient perceptions and the meaning of risk.
    Holmberg C
    Am Soc Clin Oncol Educ Book; 2015; ():e59-64. PubMed ID: 25993227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer Chemoprevention in an Integrated Health Care Setting.
    Nichols HB; Stürmer T; Lee VS; Anderson C; Lee JS; Roh JM; Visvanathan K; Muss H; Kushi LH
    JCO Clin Cancer Inform; 2017 Nov; 1():1-12. PubMed ID: 30657366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.